InfuSystem Holdings, Inc. (INFU) Earnings Call Transcripts

33 earnings calls from March 2020 to August 4, 2026

NYSEAM US Health Care Health Care Providers and Services

InfuSystem Holdings, Inc.'s Latest Earnings Call - May 11, 2026

In the 2026 Annual Meeting of Stockholders for InfuSystem Holdings, Inc., management reported a strong performance with significant shareholder engagement. While specific financial metrics such as revenue and earnings were not disclosed during the meeting, the approval of key proposals, including an amendment to increase shares under the equity incentive plan, signals a commitment to growth and shareholder value. Management did not provide updated guidance for the fiscal year, leaving investors to speculate on future performance.

Reported metrics

MetricValueContext
Shareholder Participation 83.2% (positive) Represents the percentage of shares entitled to vote at the meeting.
Number of Directors Elected 7 (positive) All nominees were elected, indicating strong support for the current board.
Equity Incentive Plan Shares Increased null (null) The specific increase in shares was not disclosed.
Independent Auditor Ratification null (null) The details regarding the auditor's performance were not discussed.

Guidance from management

Management did not provide specific forward guidance during the meeting, leaving future performance expectations unclear. No changes to previous guidance were mentioned.

What management said

If there are no questions and the vote has been cast, I declare the polls closed. I will now ask the secretary to provide the results of the voting that took place before the beginning of our meeting today. Any additional votes received during the meeting will be included in the final vote tally will be reported in a Form 8-K, which will be filed by the company in the next few days.
— Carrie Lachance, May 11, 2026 earnings call
Based on the votes received and tallied, the following nominees have been elected to the Board: Kenneth Eichenbaum, Ronald Hundzinski, Paul Gendron, Beverly Huss, Carrie Lachance, Scott Shuda and John Sviokla. of the executive officers has been approved by advisory vote. The amendment to increase the number of shares reserved under the 2021 equity incentive plan has been approved and the appointment of Grant Thornt...
— Barry Steele, May 11, 2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the lack of financial disclosures during the meeting. There was a notable absence of revenue and earnings figures, which could lead to uncertainty about the company's financial health moving forward.

Main topics on the call

Read the full InfuSystem Holdings, Inc. transcript (May 11, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About InfuSystem Holdings, Inc.

InfuSystem Holdings, Inc. (INFU) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on NYSEAM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 33 calls on record spanning March 19, 2020 to August 4, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 33 InfuSystem Holdings, Inc. earnings call transcripts on record, spanning March 19, 2020 to August 4, 2026. Based on this history, InfuSystem Holdings, Inc. reports quarterly. The most recent call on file is dated August 4, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
INFU
Exchange
NYSEAM
Country
US
Sector
Health Care
Industry
Health Care Providers and Services
Calls on record
33
First call
March 19, 2020
Most recent
August 4, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Aug 4, 2026 Read transcript
Shareholder/Analyst Calls May 11, 2026 Read transcript
Q1 FY2026 May 7, 2026 Read transcript
Q4 FY2025 Feb 24, 2026 Read transcript
Q3 FY2025 Nov 4, 2025 Read transcript
Q2 FY2025 Aug 5, 2025 Read transcript
Shareholder/Analyst Calls May 15, 2025 Read transcript
Q1 FY2025 May 8, 2025 Read transcript
Q4 FY2024 Mar 4, 2025 Read transcript
Q3 FY2024 Nov 7, 2024 Read transcript
Q2 FY2024 Aug 8, 2024 Read transcript
Shareholder/Analyst Calls May 16, 2024 Read transcript
Q1 FY2024 May 9, 2024 Read transcript
Q4 FY2023 Mar 14, 2024 Read transcript
Q3 FY2023 Nov 7, 2023 Read transcript
Q2 FY2023 Aug 3, 2023 Read transcript
Q1 FY2023 May 4, 2023 Read transcript
Q4 FY2022 Mar 15, 2023 Read transcript
Q3 FY2022 Nov 8, 2022 Read transcript
Q2 FY2022 Aug 4, 2022 Read transcript
Shareholder/Analyst Calls May 17, 2022 Read transcript
Q1 FY2022 May 5, 2022 Read transcript
Q4 FY2021 Feb 10, 2022 Read transcript
Q3 FY2021 Nov 15, 2021 Read transcript
Q2 FY2021 Aug 12, 2021 Read transcript
Shareholder/Analyst Calls May 18, 2021 Read transcript
Q1 FY2021 May 6, 2021 Read transcript
Q4 FY2020 Mar 17, 2021 Read transcript
Guidance/Update Calls Dec 15, 2020 Read transcript
Q3 FY2020 Nov 12, 2020 Read transcript
Q2 FY2020 Aug 13, 2020 Read transcript
Q1 FY2020 May 14, 2020 Read transcript
Q4 FY2019 Mar 19, 2020 Read transcript